22nd Century Group, Inc (XXII) Covered Calls

22nd Century Group, Inc. is a plant biotechnology company. The Company is focused on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding.

You can sell covered calls on 22nd Century Group, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for XXII (prices last updated Tue 4:16 PM ET):

22nd Century Group, Inc (XXII) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.93 -0.04 1.92 1.97 1.1M -73.7 0.2B
Covered Calls For 22nd Century Group, Inc (XXII)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Jul 19 2 0.10 1.87 5.3% 77.4%
Aug 16 2 0.15 1.82 8.2% 56.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

22nd Century Group, Inc. is a plant biotechnology company. Its proprietary technology allows for the levels of nicotine and other nicotinic alkaloids in the tobacco plant to be decreased or increased through genetic engineering and plant breeding. The company operates its business through smoking cessation products and modified risk tobacco products segments. Its subsidiary Goodrich Tobacco is focused on commercial tobacco products and potential modified risk cigarettes; and Hercules Pharmaceuticals LLC is focused on X-22, a prescription smoking cessation aid in development. 22nd Century Group's business roots are back to February 20, 1998. The company was founded by Joseph pandolfino on September 12, 2005 and is headquartered in Clarence, NY.